Melanie A. Ruffner

Dr. Melanie A. Ruffner


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
MRMelanie A. Ruffner
Melanie A. Ruffner
KRKathryn Ruymann
Kathryn Ruymann
SBsimona barni
simona barni
ACAntonella Cianferoni
Antonella Cianferoni
TBTerri Brown-Whitehorn
Terri Brown-Whitehorn
JSJonathan M. Spergel
Jonathan M. Spergel

1 September 2003 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
TKT.-K Kim
T.-K Kim
BSB Sharma
B Sharma
CWC.G Williams
C.G Williams
MRMelanie A. Ruffner
Melanie A. Ruffner
AMA Malik
A Malik
JEJ.H Elisseeff
J.H Elisseeff

29 January 2009 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
NBNicole R. Bianco
Nicole R. Bianco
SKSeon Hee Kim
Seon Hee Kim
MRMelanie A. Ruffner
Melanie A. Ruffner
PRPaul D. Robbins
Paul D. Robbins
Objective: We have demonstrated previously that dendritic cells (DCs) modified with immunosuppressive cytokines, and exosomes derived from DCs can suppress the onset of murine collagen‐induced arthritis (CIA) and reduce the severity of established arthritis. Indoleamine 2,3‐dioxygenase (IDO) is a tryptophan‐degrading enzyme that is important for immune regulation and tolerance maintenance. DCs expressing functional IDO can inhibit T cells by depleting them of essential tryptophan and/or by producing toxic metabolites, as well as by generating Treg cells. This study was undertaken to examine the immunosuppressive effects of bone marrow (BM)–derived DCs genetically modified to express IDO, and of exosomes derived from IDO‐positive DCs.Methods: BM‐derived DCs were adenovirally transduced with IDO or CTLA‐4Ig (an inducer of IDO), and the resulting DCs and exosomes were tested for their immunosuppressive ability in the CIA and delayed‐type hypersensitivity (DTH) murine models.Results: Both DCs and exosomes derived from DCs overexpressing IDO had an antiinflammatory effect in CIA and DTH murine models. The suppressive effects were partially dependent on B7 costimulatory molecules. In addition, gene transfer of CTLA‐4Ig to DCs resulted in induction of IDO in the DCs and in exosomes able to reduce inflammation in an IDO‐dependent manner.Conclusion: These results demonstrate that both IDO‐expressing DCs and DC‐derived exosomes are immunosuppressive and antiinflammatory, and are able to reverse established arthritis. Therefore, exosomes from IDO‐positive DCs may represent a novel therapy for rheumatoid arthritis.

7 January 2020 in Current Allergy and Asthma Reports
Verified
Journal Article
Closed access
PDF file
JCJoseph Cafone
Joseph Cafone
MRMelanie A. Ruffner
Melanie A. Ruffner
JSJonathan M. Spergel
Jonathan M. Spergel

1 February 2019 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
KWKathleen Y. Wang
Kathleen Y. Wang
JLJuhee Lee
Juhee Lee
ACAntonella Cianferoni
Antonella Cianferoni
MRMelanie A. Ruffner
Melanie A. Ruffner
ADAmy Dean
Amy Dean
TBTerri F. Brown-Whitehorn
Terri F. Brown-Whitehorn

30 October 2009 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
MRMelanie A. Ruffner
Melanie A. Ruffner
SKSeon Hee Kim
Seon Hee Kim
NBNicole R. Bianco
Nicole R. Bianco
LFLoise M. Francisco
Loise M. Francisco
ASArlene H. Sharpe
Arlene H. Sharpe
PRPaul D. Robbins
Paul D. Robbins
Costimulatory molecules, such as B7‐1/2 and PD‐L1/2 play an important role in the function of APC. The regulation of the surface levels of costimulatory molecules is one mechanism by which APC maintain the balance between tolerance and immunity. We examined the contributions of B7‐1/2 and PD‐L1/2 to the function of IL‐10‐treated, immunosuppressive DC as well as therapeutic exosomes derived from these DC. IL‐10 treatment of DC significantly downregulated surface expression of MHC II, B7‐1, B7‐2, and decreased levels of MHC I and PD‐L2. IL‐10 treatment of DC resulted in a modified costimulatory profile of DC‐secreted exosomes with a reduction in B7‐1, PD‐L1 and PD‐L2. We further demonstrate that absence of B7‐1 or B7‐2 on donor DC results in a loss of ability of IL‐10‐treated DC and their exosomes to suppress the delayed‐type hypersensitivity response, whereas IL‐10‐treated DC deficient in PD‐L1/2 as well as their secreted exosomes retained the ability to suppress delayed‐type hypersensitivity responses. We conclude that B7‐1 and B7‐2, but not PD‐L1 and PD‐L2, on IL‐10‐treated DC and DC‐derived exosomes play a critical role in immunosuppressive functions of both DC and exosomes.